NeuroSense completed a Phase 2a clinical trial which met its safety and efficacy endpoints including reducing functional and ...

Matteo Materazzi's battle against a rare form of ALS has prompted his wife to launch a fundraiser to fund personalized ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's ...

The amendment states that no funds appropriated in the fiscal 2026 spending bill can be used to increase the proportion of ...

Neuralink launched the first European clinical trial in the UK to test brain implants that let paralyzed patients control ...

The Boxing Event brings fighters from across Texas to the ring — all to raise money for gym, nonprofits and raise awareness ...

Neuralink is crossing the pond. Elon Musk’s brain chip is due to start clinical trials in Great Britain, and he is inviting ...

Elon Musk Neuralink is doing a clinical study in collaboration with the UK to get approval for their chip in their citizens' ...

Elon Musk 's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical ...

The breakome is a new layer in the multiomics landscape—alongside the genome, transcriptome, proteome, and interactome. While it hasn’t traditionally been included among these other omics, we consider ...

Neuralink to study mind-controlled tech in UK patients with paralysis, Neuralink to test chip implants in the brain in the UK for people who are suffering from paralysis Elon Musk’s Neuralink ...